JP2015531873A5 - - Google Patents

Download PDF

Info

Publication number
JP2015531873A5
JP2015531873A5 JP2015531492A JP2015531492A JP2015531873A5 JP 2015531873 A5 JP2015531873 A5 JP 2015531873A5 JP 2015531492 A JP2015531492 A JP 2015531492A JP 2015531492 A JP2015531492 A JP 2015531492A JP 2015531873 A5 JP2015531873 A5 JP 2015531873A5
Authority
JP
Japan
Prior art keywords
amount
subject
sample
fgf
specifically binds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015531492A
Other languages
English (en)
Japanese (ja)
Other versions
JP6247302B2 (ja
JP2015531873A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/056706 external-priority patent/WO2014040759A1/en
Publication of JP2015531873A publication Critical patent/JP2015531873A/ja
Publication of JP2015531873A5 publication Critical patent/JP2015531873A5/ja
Application granted granted Critical
Publication of JP6247302B2 publication Critical patent/JP6247302B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015531492A 2012-09-12 2013-03-28 異常な短縮率（ｆｒａｃｔｉｏｎａｌｓｈｏｒｔｅｎｉｎｇ）を持つ患者の同定 Active JP6247302B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12184085 2012-09-12
EP12184085.4 2012-09-12
PCT/EP2013/056706 WO2014040759A1 (en) 2012-09-12 2013-03-28 Identification of patients with abnormal fractional shortening

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017220660A Division JP6615848B2 (ja) 2012-09-12 2017-11-16 異常な短縮率（ｆｒａｃｔｉｏｎａｌ ｓｈｏｒｔｅｎｉｎｇ）を持つ患者の同定

Publications (3)

Publication Number Publication Date
JP2015531873A JP2015531873A (ja) 2015-11-05
JP2015531873A5 true JP2015531873A5 (https=) 2016-05-19
JP6247302B2 JP6247302B2 (ja) 2017-12-13

Family

ID=46826365

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015531492A Active JP6247302B2 (ja) 2012-09-12 2013-03-28 異常な短縮率（ｆｒａｃｔｉｏｎａｌｓｈｏｒｔｅｎｉｎｇ）を持つ患者の同定
JP2017220660A Active JP6615848B2 (ja) 2012-09-12 2017-11-16 異常な短縮率（ｆｒａｃｔｉｏｎａｌ ｓｈｏｒｔｅｎｉｎｇ）を持つ患者の同定

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017220660A Active JP6615848B2 (ja) 2012-09-12 2017-11-16 異常な短縮率（ｆｒａｃｔｉｏｎａｌ ｓｈｏｒｔｅｎｉｎｇ）を持つ患者の同定

Country Status (7)

Country Link
US (3) US20150185230A1 (https=)
EP (3) EP3428649B1 (https=)
JP (2) JP6247302B2 (https=)
CN (1) CN104620111B (https=)
CA (1) CA2883890C (https=)
ES (2) ES2913539T3 (https=)
WO (1) WO2014040759A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112014007007B1 (pt) 2011-10-17 2022-04-19 F. Hoffmann-La Roche Ag Método in-vitro para diferenciação precoce da apoplexia isquêmica cardioembólica, uso de uma troponina cardíaca e dispositivo de diferenciação precoce da apoplexia isquêmica cardioembólica
EP3413052B1 (en) 2014-03-26 2022-12-28 Roche Diagnostics GmbH Igfbp7 for diagnosing diastolic dysfunction
CN107110871B (zh) 2014-10-29 2019-09-27 豪夫迈·罗氏有限公司 用于死亡的风险预测的生物标志物
CN108139409B (zh) 2015-10-08 2020-07-24 豪夫迈·罗氏有限公司 当在外科手术之前测量时用于预测aki的风险的igfbp7
WO2017125406A1 (en) * 2016-01-19 2017-07-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods of predicting left ventricular remodeling in subjects suffering from hypertension
BR112019025313A2 (pt) * 2017-05-30 2020-06-23 Abbott Laboratories Métodos para auxílio no diagnóstico e avaliação de uma lesão cerebral traumática leve em um indivíduo humano usando troponina cardíaca i
BR112020011454A2 (pt) 2017-12-13 2021-02-09 F. Hoffmann-La Roche Ag métodos para prever o risco de acidente vascular, para prever o risco de acidente vascular cerebral e para aprimorar a precisão da previsão e usos do (i) biomarcador ang-2 e/ou do biomarcador igfbp7
JP7024576B2 (ja) * 2018-04-20 2022-02-24 オムロンヘルスケア株式会社 電子血圧計および心不全検出器
US12322100B2 (en) 2018-12-11 2025-06-03 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US12400762B2 (en) 2018-12-11 2025-08-26 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views
US12333413B1 (en) * 2024-03-01 2025-06-17 Mayo Foundation For Medical Education And Research Apparatus and method for training an artificial intelligence-supported diagnostic assessment tool

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
GB9211686D0 (en) 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
US6709855B1 (en) 1998-12-18 2004-03-23 Scios, Inc. Methods for detection and use of differentially expressed genes in disease states
EP1379869A4 (en) * 2001-03-15 2004-08-11 Xiao Yong Fu METHOD FOR THERAPEUTICALLY TREATING A CLINICALLY DETECTED CARDIOPATHOLOGICAL FORM IN A MAMMAL
US7632647B2 (en) 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US7713705B2 (en) * 2002-12-24 2010-05-11 Biosite, Inc. Markers for differential diagnosis and methods of use thereof
ATE458199T1 (de) 2001-05-04 2010-03-15 Biosite Inc Diagnostische marker der akuten koronaren syndrome und ihre verwendungen
EP1451579A4 (en) * 2001-11-19 2005-12-28 Protometrix Inc METHOD OF USING NON-ANTIBODY PROTEIN FOR DETECTING AND MEASURING AN ANALYTE
JP2005291899A (ja) * 2004-03-31 2005-10-20 Akira Matsumori 心疾患の検査法
US8563328B2 (en) * 2004-07-26 2013-10-22 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
US20080027330A1 (en) * 2006-05-15 2008-01-31 Endothelix, Inc. Risk assessment method for acute cardiovascular events
WO2008060618A2 (en) * 2006-11-15 2008-05-22 University Of Florida Research Foundation Use of genetic determinants in cardiovascular risk assessment
JP2010517023A (ja) * 2007-01-25 2010-05-20 エフ．ホフマン−ラ ロシュ アーゲー 心不全の評価におけるｉｇｆｂｐ−７の使用
AU2008246125B2 (en) * 2007-04-26 2013-01-24 Genera Istrazivanja D.O.O. Blood biomarkers for bone fracture and cartilage injury
CA2681667A1 (en) * 2007-05-18 2008-11-27 Duke University Serum biomarkers for the early detection of lung cancer
US20110183434A1 (en) * 2008-01-17 2011-07-28 Myles Wolf Diagnostic methods and kits using fibroblast growth factor-23
NZ593221A (en) * 2008-11-06 2012-10-26 Musc Found For Res Dev Detecting and monitoring left ventricular hypertrophy and congestive heart failure by profiling biomarkers
JP2012522746A (ja) 2009-04-01 2012-09-27 レツク・フアーマシユーテイカルズ・デー・デー 活性メチレン基のジメチル化の方法
EP2425245B1 (en) 2009-04-27 2016-10-05 Roche Diagnostics GmbH Use of endostatin as a marker of heart failure
WO2011012268A1 (en) 2009-07-27 2011-02-03 Roche Diagnostics Gmbh Use of mimecan in the assessment of heart failure
WO2011075744A1 (en) * 2009-12-20 2011-06-23 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011117371A2 (en) * 2010-03-26 2011-09-29 Pronota N.V. Ltbp2 as a biomarker for renal dysfunction
US20120142632A1 (en) * 2010-08-04 2012-06-07 St. Vincent's Institute Of Medical Research Diagnostic and prognostic assay
CN105044349B (zh) * 2010-08-26 2018-04-06 弗·哈夫曼-拉罗切有限公司 生物标志物在评估从动脉高血压向心力衰竭的早期转变中的用途
KR101882533B1 (ko) * 2010-08-31 2018-07-26 교와 메덱스 가부시키가이샤 섬유아세포 증식 인자-２３ 의 측정 방법 및 측정 시약

Similar Documents

Publication Publication Date Title
JP2015531873A5 (https=)
Winau et al. High-sensitive troponin is associated with subclinical imaging biosignature of inflammatory cardiovascular involvement in systemic lupus erythematosus
Heberton et al. Usefulness of psoas muscle area determined by computed tomography to predict mortality or prolonged length of hospital stay in patients undergoing left ventricular assist device implantation
Klok et al. External validation of a simple non-invasive algorithm to rule out chronic thromboembolic pulmonary hypertension after acute pulmonary embolism
Andruchow et al. Contemporary emergency department management of patients with chest pain: a concise review and guide for the high-sensitivity troponin era
Rusconi et al. Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure
Jing et al. Ambulatory systolic blood pressure and obesity are independently associated with left ventricular hypertrophic remodeling in children
Ray et al. Pulmonary arterial stiffness assessed by cardiovascular magnetic resonance imaging is a predictor of mild pulmonary arterial hypertension
Mather et al. Relationship of cardiac biomarkers and reversible and irreversible myocardial injury following acute myocardial infarction as determined by cardiovascular magnetic resonance
Gawor et al. Circulating biomarkers of hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy assessed by cardiac magnetic resonance
JP2015504519A5 (https=)
Kobayashi et al. Urinary 8-hydroxy-2′-deoxyguanosine as a novel biomarker of inflammatory activity in patients with cardiac sarcoidosis
Ross et al. Are troponin and B-type natriuretic peptides useful biomarkers for the diagnosis of systemic sclerosis heart involvement? A systematic literature review
Rasmussen et al. Danish study of Non-Invasive testing in Coronary Artery Disease 2 (Dan-NICAD 2): Study design for a controlled study of diagnostic accuracy
CN109891243A (zh) 心房纤颤和中风的评价中的循环esm-1 (endocan)
Wei et al. Diastolic dysfunction measured by cardiac magnetic resonance imaging in women with signs and symptoms of ischemia but no obstructive coronary artery disease
Deraz et al. Assessment of ventricular dysfunction in Egyptian children with Beta-thalassemia major
Ungar et al. A preliminary 18F-FDG-PET/MRI study shows increased vascular inflammation in moderate-to-severe atopic dermatitis
Schaaf et al. Which high-sensitivity troponin variable best characterizes infarct size and microvascular obstruction?
Yamasaki et al. Clinical impact of left ventricular eccentricity index using cardiac MRI in assessment of right ventricular hemodynamics and myocardial fibrosis in congenital heart disease
Fairley et al. Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis
JP2015004664A (ja) アルツハイマー病罹患リスクを検出する方法
Casals et al. Impact of ultrasensitive cardiac troponin I dynamic changes in the new universal definition of myocardial infarction
He et al. Diffusing capacity of lungs for carbon monoxide associated with subclinical myocardial impairment in systemic sclerosis: a cardiac MR study
Hanneman et al. Cardiovascular CT in the diagnosis of pericardial constriction: predictive value of inferior vena cava cross-sectional area